HYBRIGEN

DEVELOPING PROTEOMIC PLATFORM TECHNOLOGIES ON BEHALF OF PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES, NAMELY, DEVELOPING NEW PROCESSES BY WHICH HIGH VALUE DRUG TARGETS MIGHT BE DISCOVERED WHICH IN TURN CAN BE USED BY PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES FOR NEW DRUG DEVELOPMENT ACTIVITIES; AND HELPING PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES ACCELERATE DISCOVERY AND DEVELOPMENT OF PROMISING NEW DRUGS